2nd Rare CNS and Neurodevelopmental Drug Development Summit
Developing New Outcome Measures, Functional Biomarkers and Clinical Research Regulatory Frameworks for Disease-Modifying Therapeutics Across Neurodevelopmental and Rare, Genetic CNS Disorders